General Information
Product name
Extraction Buffer
REACH No
The
1.2.1 Relevant identified uses
Extraction buffer is for use in conjunction with LumiraDx swab based assays, for example SARS-CoV-2, and is designed to lyse and inactivate the virus to release viral antigen. Each vial of extraction buffer is for single use
Emergency telephone
00800 58647239
Icons in SDS
Company Information
company name
LumiraDx UK Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
customerservices@lumiradx.com
Section 2
Principle Routes of Exposure
Ingestion, eye contact and/or skin contact Ingestion: Ingestion of extraction buffer may cause nausea, vomiting, restlessness, diarrhoea, headache, dizziness, weakness, blurred vision, dyspnoea, hypotension, tachycardia, bradycardia, tachypnoea, hypothermia, acidosis and convulsions. Skin contact: Contact with skin may cause irritation. Eye contact: Contact with eyes may cause irritation. Hazardous decomposition products: When exposed to fire, produces normal products of combustion. Unusual fire, explosion and reactivity hazards: The LumiraDx Extraction Buffer contains Sodium azide, which may over a period of time react with metal in plumbing systems to form an accumulation of explosive metallic azide, therefore it should be discarded with a large quantity of water.
